Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia. | Am J Hematol | 2023 | 36861732 | PubTator, text mining | PubMed |
| m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion. | Mol Cancer | 2023 | 36859310 | PubTator, text mining | PubMed |
| Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia. | Exp Hematol Oncol | 2023 | 36849955 | PubTator, text mining | PubMed |
| (R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers. | Cancer Discov | 2023 | 36847506 | PubTator, text mining | PubMed |
| Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients. | Front Oncol | 2023 | 36845715 | PubTator, text mining | PubMed |
Risk factors for post-transplant relapse and survival in younger adult patients with t(8;21)(q22;q22) acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study. | Front Oncol | 2023 | 36845681 | PubTator, text mining | PubMed |
| Thyroid hormone action controls multiple components of cell junctions at the ventricular zone in the newborn rat brain. | Front Endocrinol (Lausanne) | 2023 | 36843608 | PubTator, text mining | PubMed |
| Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia. | Ann Lab Med | 2023 | 36843401 | PubTator, text mining | PubMed |
| Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. | Signal Transduct Target Ther | 2023 | 36843114 | PubTator, text mining | PubMed |
| Investigation of the Pathogenic Mechanism of Ciprofloxacin in Aortic Aneurysm and Dissection by an Integrated Proteomics and Network Pharmacology Strategy. | J Clin Med | 2023 | 36835806 | PubTator, text mining | PubMed |
| Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 36834627 | PubTator, text mining | PubMed |
| Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML. | Int J Mol Sci | 2023 | 36834477 | PubTator, text mining | PubMed |
| Fusion Gene-Based Classification of Variant Cytogenetic Rearrangements in Acute Myeloid Leukemia. | Genes (Basel) | 2023 | 36833323 | PubTator, text mining | PubMed |
| Tumor Androgen Receptor Protein Level Is Positively Associated with a Better Overall Survival in Melanoma Patients. | Genes (Basel) | 2023 | 36833272 | PubTator, text mining | PubMed |
| The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. | Cancers (Basel) | 2023 | 36831561 | PubTator, text mining | PubMed |
| One-Carbon (Folate) Metabolism Pathway at Birth and Risk of Childhood Acute Lymphoblastic Leukemia: A Biomarker Study in Newborns. | Cancers (Basel) | 2023 | 36831356 | PubTator, text mining | PubMed |
| Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis. | Cancers (Basel) | 2023 | 36831347 | PubTator, text mining | PubMed |
| The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN. | Cells | 2023 | 36831211 | PubTator, text mining | PubMed |
| The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism. | Biomolecules | 2023 | 36830642 | PubTator, text mining | PubMed |
| Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. | Curr Oncol | 2023 | 36826113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=21